Oncology
Latest News
Gardasil 9 at 10 Years: Vaccine Protects Against Multiple Cancers
The WHO has predicted that the 21st century may be the last to experience HPV-associated cancers, currently responsible for more than...
Feature
Outpatient CAR T: Safe, Effective, Accessible
'The future of CAR T-cell therapy lies in balancing safety with accessibility,' says expert.
From the Journals
Are Three Cycles of Chemotherapy as Effective as Six for Retinoblastoma?
Participants in a trial at two eye centers in China were randomly assigned to receive either three or six cycles of CEV chemotherapy after...
Latest News
One-Dose HPV Vaccine Program Would Be Efficient in Canada
The model projected that a noninferior one-dose, gender-neutral HPV vaccination program would avert a similar number of cervical cancer cases,...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...
Commentary
Low HPV Vaccination in the United States Is a Public Health ‘Failure’
For this vaccine, which is incredibly safe and incredibly effective, in this country, only 38.6% have received even a single dose.
From the Journals
Ancient Viruses in Our DNA Hold Clues to Cancer Treatment
Targeting remnants of a virus in our DNA could lead to more effective cancer treatment with fewer side effects.
Feature
Greater Transparency of Oncologists’ Pharma Relationships Needed
Reducing industry payments to hematologists and oncologists could benefit patients, say experts.
From the Journals
Should Cancer Trial Eligibility Become More Inclusive?
A new study highlights the potential benefits of broadening eligibility criteria for clinical trials.